Orris

Typhoid injectable treatment

Reading File
Finding Sources
Finding Sources
Searching PubMed

"typhoid fever"[MeSH] AND ceftriaxone

Reading File
Reading File
Reading File
Reading File

Injectable (Parenteral) Treatment for Typhoid Fever (Enteric Fever)

First-line parenteral options
  • Ceftriaxone (or another third-generation cephalosporin such as cefotaxime) is the standard empiric injectable choice for typhoid fever that is known or suspected to be multidrug-resistant (MDR), especially for moderate-severe illness or when oral therapy isn't feasible - Red Book 2021, p. 1023; Goldman-Cecil Medicine, p. 2117-2124.
    • Typical dosing (adult): ceftriaxone 2 g IV once daily.
    • Pediatric dosing: ~50-75 mg/kg/day IV once daily.
    • Duration: at least 7-10 days for uncomplicated disease; some experts extend to 10-14 days for bacteremic/severe cases.
  • Azithromycin can also be given IV in patients who cannot tolerate oral therapy, though oral azithromycin is usually preferred given excellent bioavailability; relapse rates are reported to be lower with azithromycin than with ceftriaxone or fluoroquinolones - Red Book 2021, p. 1024.
Extensively drug-resistant (XDR) typhoid
Since 2016, an ongoing epidemic in Pakistan has produced S. Typhi strains resistant to ceftriaxone, ampicillin, ciprofloxacin, and TMP-SMX - these isolates remain susceptible only to azithromycin and carbapenems (e.g., meropenem). Cases have been reported in returning travelers to the US and UK, so travel history to Pakistan/South Asia should prompt consideration of a carbapenem if ceftriaxone response is poor - Red Book 2021, p. 1023.
Fluoroquinolones
Ciprofloxacin (IV or oral) was historically first-line, but most typhoid cases diagnosed in the US and returning travelers from South Asia now show fluoroquinolone non-susceptibility, so it should not be used empirically in that context - Red Book 2021, p. 1023; Tintinalli's Emergency Medicine, p. 3384-3387.
Severe/complicated disease (delirium, obtundation, stupor, coma, shock)
Add IV dexamethasone: initial dose 3 mg/kg, then 1 mg/kg every 6 hours for a total of 48 hours, alongside antibiotics - Red Book 2021, p. 1024; Yamada's Textbook of Gastroenterology, p. 2479-2488.
Chronic carrier state / relapse
  • Oral ciprofloxacin or norfloxacin for 4 weeks is preferred for carrier eradication.
  • High-dose parenteral (IV) ampicillin is an alternative injectable option if oral fluoroquinolone therapy isn't tolerated or feasible, provided the strain is susceptible - Goldman-Cecil Medicine, p. 2117-2124.
  • Relapse (occurring in up to 17% within 4 weeks, more common in immunocompromised patients) may require retreatment and longer duration of therapy.

Recent evidence check

A 2022 Cochrane systematic review specifically evaluated cephalosporins (including ceftriaxone) for enteric fever treatment, and a 2024 systematic review compared oral azithromycin against other antimicrobials (including ceftriaxone) across age groups - both are consistent with the guidance above (PMID: relevant Cochrane review cited in Goldman-Cecil references; azithromycin review PMID 39623850). No findings from these reviews contradict the standard approach summarized here, though local resistance patterns should always guide final antibiotic choice.
Bottom line: Ceftriaxone (or cefotaxime) IV is the default injectable treatment for typhoid fever, azithromycin (oral or IV) is an excellent alternative with lower relapse rates, and meropenem is reserved for XDR strains. Avoid empiric fluoroquinolones given rising resistance, and add IV dexamethasone only for severe/complicated cases with neurological or shock features.
This is a shared conversation. Sign in to Orris to start your own chat.